Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumihito Nobusawa

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
The American Journal of Surgical Pathology|March 13, 2026
BEND2 Immunohistochemistry as a Useful Diagnostic Marker for Astroblastomas With BEND2 FusionHaruna Okuno, Takuma Nakashima, Yasuhito Arai, et al.
Cancer Science|April 25, 2026
A Nationwide Central Diagnosis for Pediatric CNS Tumors in Japan: The JCCG Brain Tumor and Pathology CommitteesYoshiko Nakano, Junko Hirato, Takako Yoshioka, et al.
Neuro-Oncology|October 23, 2022
Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatinSatoshi Nakata, Junko Murai, Masayasu Okada, et al.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
The American Journal of Surgical Pathology|March 13, 2026
BEND2 Immunohistochemistry as a Useful Diagnostic Marker for Astroblastomas With BEND2 FusionHaruna Okuno, Takuma Nakashima, Yasuhito Arai, et al.
Cancer Science|April 25, 2026
A Nationwide Central Diagnosis for Pediatric CNS Tumors in Japan: The JCCG Brain Tumor and Pathology CommitteesYoshiko Nakano, Junko Hirato, Takako Yoshioka, et al.
Neuro-Oncology|October 23, 2022
Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatinSatoshi Nakata, Junko Murai, Masayasu Okada, et al.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Pageof 13